Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000575325 | SCV000672399 | pathogenic | Hereditary cancer-predisposing syndrome | 2016-10-11 | criteria provided, single submitter | clinical testing | The c.754delC pathogenic mutation, located in coding exon 6 of the TP53 gene, results from a deletion of one nucleotide at nucleotide position 754, causing a translational frameshift with a predicted alternate stop codon (p.L252Sfs*93). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |